Zhejiang Ausun Pharmaceutical Co Ltd Strategic Asset Allocation Index
Zhejiang Ausun Pharmaceutical Co Ltd strategic asset allocation index. Zhejiang Ausun Pharmaceutical Co Ltd (603229) has a Strategic Asset Allocation Index of 48.2% as of June 2023. Strategic assets (PP&E of CN¥1.01 Billion plus long-term investments of CN¥-) total CN¥1.01 Billion, measured against net assets of CN¥2.10 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 603229 net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Zhejiang Ausun Pharmaceutical Co Ltd (2016–2022)
Strategic asset allocation index of Zhejiang Ausun Pharmaceutical Co Ltd from 2016 to 2022. This chart shows how Zhejiang Ausun Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of June 2023, the index stands at 48.2%, representing strategic assets of CN¥1.01 Billion against net assets of CN¥2.10 Billion CNY. Check Zhejiang Ausun Pharmaceutical Co Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
Zhejiang Ausun Pharmaceutical Co Ltd Strategic Asset Allocation Index by Year (2016–2022)
Zhejiang Ausun Pharmaceutical Co Ltd strategic asset allocation index by year from 2016 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Zhejiang Ausun Pharmaceutical Co Ltd from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Zhejiang Ausun Pharmaceutical Co Ltd stock valuation.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 65.1% | CN¥950.94 Million | CN¥950.94 Million | CN¥- | CN¥1.46 Billion | ▲ +17.2 pp |
| 2021 | 47.9% | CN¥601.46 Million | CN¥601.46 Million | CN¥- | CN¥1.25 Billion | ▲ +21.3 pp |
| 2020 | 26.6% | CN¥299.92 Million | CN¥299.92 Million | CN¥- | CN¥1.13 Billion | ▼ -11.5 pp |
| 2019 | 38.1% | CN¥245.82 Million | CN¥245.82 Million | CN¥- | CN¥645.19 Million | ▲ +0.0 pp |
| 2018 | 38.1% | CN¥227.55 Million | CN¥227.55 Million | CN¥- | CN¥597.60 Million | ▲ +3.9 pp |
| 2017 | 34.1% | CN¥192.80 Million | CN¥192.80 Million | CN¥- | CN¥564.93 Million | ▼ -34.6 pp |
| 2016 | 68.7% | CN¥167.23 Million | CN¥167.23 Million | CN¥- | CN¥243.30 Million | — |